Boards & Committees - Board of Directors
BOARD OF DIRECTORS
October 18-19, 2014
Boston, MA, USA
The ISHLT Board of Directors is comprised of 15 individuals: the four Officers (Past President, President, President-Elect, and Secretary-Treasurer) and eleven Directors, reflecting the geographic and disciplinary constituencies of the Society.
The Editor of the Journal of Heart and Lung Transplantion, the Medical Director of the Registry, the Annual Meeting Scientific Program Chair, the Chair of the Development Committee, and the Executive Director serve as ex-officio, non-voting members of the Board.
COMMITTEE MEMBERS:EXECUTIVE OFFICERS:
University Heart Center Hamburg
firstname.lastname@example.orgProf. Reichenspurner is currently the Medical Director, University Heart Center Hamburg, and Professor and Chairman of the Department of Cardiovascular Surgery. He was trained in Munich, Cape Town and Stanford University. He is actively involved in cardiac and pulmonary transplantation since 1985 and wrote his MD - and 2 PhD - theses about cardio-pulmonary transplantation and immunology. He and his team have published over 460 articles, many of those focusing on transplantation. In addition, he is the spokesman of the Federal Medical Chamber in Germany for heart and lung transplantation and Head of the University Transplant Center in Hamburg.
Duke University Medical Center
Durham, North Carolina, USA
email@example.comDr. Davis is Professor of Cardiovascular & Thoracic Surgery and the Director of Transplant Services at Duke University Medical Center. He received his MD in 1984 from the University of California Los Angeles David Geffen School of Medicine. He received his post graduate training at Duke University Medical Center and Barnes-Jewish Hospital, Washington University in St. Louis, Missouri. His clinical interests are in adult cardiac surgery and cardiothoracic transplantation (lung, heart-lung, and heart); coronary artery revascularization, including minimally invasive and hybrid procedures; valve repair and replacement surgery; surgical treatment of chronic thromboembolic pulmonary hypertension and chronic atrial fibrillation.
St. Vincent's Hospital
firstname.lastname@example.orgProfessor Glanville trained in Sydney, Brompton Hospital, London and Stanford University, California. Currently working as a specialist in Lung Transplantation at St. Vincent's Hospital Sydney, he is actively involved with international trials into new immunosuppressive and anti-viral agents. He is Global Principal Investigator for the European and Australian Investigators in Lung Transplantation CeMyLungs trial, and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. He has authored over 140 publications including approaches to antibody mediated rejection, bronchoscopic surveillance, RSV, CMV, Chlamydia and mycobacteria. He is the senior author of the International Guidelines for Lung Transplantation, foundation director of Outcomes Australia and a foundation member of ShareLife Australia.
St. Louis Children's Hospital
St. Louis, Missouri, USA
email@example.comStuart Sweet, MD, is Professor of Pediatrics at Washington University and Medical Director of the Pediatric Lung Transplant Program at St. Louis Children’s Hospital in St. Louis, Missouri. He received graduate and medical degrees at the University of Michigan and post-graduate training at Washington University. His current research focuses on lung disease in children and improved understanding of the important factors determining outcome after lung transplantation. He is currently leading an NIH funded multicenter collaborative study of the role viral infections play in pediatric lung transplant. Dr. Sweet has active interests in organ allocation (he is currently Secretary of the OPTN/UNOS Board of Directors) and the use of information technology in medicine (he is chair of the Electronic Health Records committee at St. Louis Children's Hospital).DIRECTORS:
University Hospital Zurich
Zurich, SWITZERLANDchristian_benden@yahoo.deDr. Christian Benden is the Medical Director of Lung Transplantation at the University Hospital Zurich and a Reader in Pulmonology and Transplant Medicine at the University of Zurich, Switzerland. Dr. Benden completed his pediatric training in Hannover (Germany) and London (United Kingdom). In addition, he trained in Pediatric Pulmonology and received specialist training in lung transplantation in London and Zurich. Dr. Benden is a well-recognized Pediatric Lung Transplant Physician, and a former Chair of the ISHLT Scientific Council on Pediatric Transplantation. His research interests include clinical aspects of lung transplantation, particularly in children and adolescents, experimental aspects of chronic lung allograft dysfunction, and cystic fibrosis lung disease.
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, USA
513-636-9101mailto:Lara.Danziger-Isakov@cchmc.orgLara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is Associate Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and complete her residency in Pediatrics at the Cleveland Clinic. She also completed a fellowship in Pediatric Infectious Diseases at Saint Louis Children's Hospital. Dr. Danziger-Isakov is board-certified in Pediatrics and Pediatric Infectious Diseases by the American Board of Pediatrics. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on pediatric and adult lung transplantation. In addition, Dr. Danziger-Isakov participates in clinical trials to evaluate both new infectious disease therapies and new method of detection for infectious diseases.
Newcastle Upon Tyne, UK
firstname.lastname@example.orgAndrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as an Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.
Yale New Haven Hospital
New Haven, CT, USA
email@example.comAs a physician-scientist and transplant immunologist, Dr. Goldstein examines how the innate immune system, in particular Toll-like receptors, impact alloimmunity and transplant tolerance. His work as a board certified transplant cardiologist affords him insights into whether preclinical immunological studies are relevant to solid organ transplantation. In addition, his research involves studies on how aging impacts innate immunity and the role of aging on alloimmmunity. In particular, his laboratory has discovered new pathways by which aging alters inflammation during acute viral infections, atherosclerosis, and information that age-induced inflammatory responses impact the tempo of acute allograft rejection and transplant tolerance.
University of Wisconsin
Madison, WI, USA
firstname.lastname@example.orgMaryl R. Johnson, MD, received her medical degree from the University of Iowa College of Medicine where she also completed postgraduate training in Internal Medicine and Cardiovascular Diseases. She joined the faculty at Iowa and was instrumental in the establishment of a cardiac transplant program, serving as the Medical Director of Cardiac Transplantation from 1984-1988. Her subsequent career has been entirely devoted to the care of patients with heart failure and following cardiac transplantation. She served as the Associate Medical Director of the Cardiac Transplant Program at Loyola University Medical Center from 1988-1994, Associate Medical Director of the Rush Heart Failure and Cardiac Transplant Program from 1994-1997, and Medical Director, Heart Failure and Transplantation at Northwestern Memorial Hospital from 1998-2002. She moved to the University of Wisconsin as Medical Director of Heart Failure and Transplantation and Professor of Medicine in July 2002. Dr. Johnson's clinical interests are in the care of patients with severe congestive heart failure, including the use of mechanical circulatory support devices and cardiac transplantation. She has a particular interest in the treatment and outcome of congestive heart failure in women. Her research interests include the use of mechanical assistance in patients with severe heart failure and the coronary artery disease which develops in cardiac transplant recipients. She has also been an investigator in many of the multicenter trials evaluating new agents for the medical treatment of heart failure.
email@example.comA/Prof Bronwyn Levvey is the clinical lung transplant nursing team leader of the Lung Transplant Service at The Alfred Hospital, Melbourne Australia. Appointed as Adjunct Clinical Associate Professor in the Department of Medicine, Faculty of Nursing & Health Sciences at Monash University (Melbourne) in 2008 in recognition of her strong commitment to transplantation nursing education and clinical research, she has authored or co-authored more than 60 peer review scientific publications. Since 2005, a major focus of A/Prof Levvey’s clinical research has been the successful evolution and development of Category III DCD Lung donation and transplantation in Australia. An ISHLT member since 2000, she is the current National President of the Transplant Nurses Association (TNA) of Australia, a member of TTS and the Transplantation Society of Australia & New Zealand (TSANZ), and is a member of several Australian government organ donation and transplantation advisory boards.
University of Michigan Health System
Ann Arbor, Michigan, USA
firstname.lastname@example.orgFrancis D. Pagani, M.D., Ph.D. is the Otto Gago, MD Professor of Surgery at the University of Michigan. He is the Surgical Director of the Heart Transplant Program and the Center for Circulatory Support at the University of Michigan Health System. Dr. Pagani earned his doctorate in pharmacology and medical degree from Georgetown University in 1986 and completed his Chief Residency in Surgery at Georgetown University in 1993. Dr. Pagani completed a post doctural fellowship in cardiac research at the University of Massachusetts from 1988 to 1990. Dr. Pagani joined the University of Michigan faculty in 1995. His research focuses on the use of mechanical circulatory support in the treatment of end-stage heart disease and also has investigated the use of cellular transplantation for myocardial regeneration. His clinical interests include adult cardiac surgery for advanced heart disease, valvular heart disease, heart transplantation, and mechanical circulatory support.
University of Maryland School of Medicine
Baltimore, MD, USA
email@example.comDr. Myung Park is Associate Professor of Medicine and Director of the Pulmonary Vascular Diseases Program at the University of Maryland School of Medicine. Her focus of interest in research and clinical practice is in Pulmonary Hypertension. She completed her MD and residency from Temple University School of Medicine, and completed a fellowship in Heart Failure & Cardiac Transplant at the Cleveland Clinic, and a fellowship in Cardiovascular Diseases at the Medical College of Virginia Hospitals.
Duke University Medical Center
Durham, North Carolina, USA
firstname.lastname@example.orgDr. Joseph Rogers is Professor of Medicine, Senior Vice Chief for Clinical Affairs in the Division of Cardiology, and Medical Director of the Duke Cardiac Transplant and Mechanical Circulatory Support Program at Duke University. Dr. Rogers completed his medical training at the University of Nebraska College of Medicine, and completed a fellowship in Cardiology at Washington University Barnes-Jewish Hospital in St. Louis, Missouri. His clinical interests are in acute and chronic heart failure; cardiac transplantation; mechanical circulatory support.
University of Pittsburgh/Presbyterian
Pittsburgh, Pennsylvania, USA
email@example.comJeffrey Teuteberg, MD, is an Assistant Professor of Medicine, Associate Director of the Cardiac Transplant Program, and a member of the Heart Failure/Cardiac Transplant section of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Medical Center, where he specializes in the care of patients with advanced cardiomyopathies, cardiac transplantation, ventricular assist devices and pulmonary hypertension. He has particular interests in advanced heart failure and the transition to cardiac transplantation and ventricular assist devices. Dr. Teuteberg graduated from the University of Chicago, Pritzker School of Medicine, in 1992 and remained at the University of Chicago for his Internal Medicine Residency and general Cardiovascular Fellowship, during which he spent a year as the Chief Medical Resident. Dr. Teuteberg received his Heart Failure and Cardiac Transplant training at Brigham and Women's hospital in Boston.EX-OFFICIO BOARD MEMBERS:
University of Alberta
Edmonton, Alberta, CANADA
firstname.lastname@example.orgDr. Lori West is the Director of Heart Transplantation Research and a Professor of Pediatrics, Surgery and Immunology at the University of Alberta - one of the largest heart transplant programs in the world. Dr. West completed her pediatric residency at Harbor-UCLA Medical Center. She trained in pediatric cardiology at the Hospital for Sick Children, Toronto, and subsequently in pediatric transplant cardiology at Pittsburgh Children's Hospital, Loma Linda University Medical Center and Columbia-Presbyterian Children's Hospital. She obtained her PhD for specialized training in transplant immunology research at Oxford University and works in the role of a clinician-scientist.
University of Utah
Salt Lake City, Utah, USA
email@example.comJosef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCP*Hahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic. Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support.
Professor of Medicine, Harvard Medical School
Executive Director, Center for Advanced Heart Disease, Brigham and Women's Hospital
Boston, Massachusetts, USA
firstname.lastname@example.orgDr. Mehra, an internationally recognized cardiologist with expertise in the treatment of heart failure and heart muscle damage, cardiac transplantation and mechanical circulatory devices, is professor of Medicine at Harvard Medical School and Executive Director of the Center for Advanced Heart Disease at the Brigham and Women's Hospital in Boston, MA (USA). He obtained his cardiovascular training at the Ochsner Clinic Foundation, where he sub-specialized in the field of advanced heart failure and cardiac transplantation. He is board certified in internal medicine and cardiovascular diseases. His specific research interests in cardiac transplantation focus on post-transplant coronary arterial disease, new immunosuppressive therapy to improve heart transplant outcomes, and bringing genomic and proteomic science (the study of protein interactions in the body) to the bedside. In the field of heart failure, his research has focused on the role of new devices and novel serum markers to guide diagnosis and therapy.
Medical University of Vienna
email@example.comBio coming soon...
The University of Chicago Medicine & Biological Sciences
Chicago, Illinois, USA
firstname.lastname@example.org Christopher Wigfield, MD, MD, FRCS(C/Th), is Assistant Professor of Cardiothoracic Surgery at The University of Chicago. Dr. Wigfield received his clinical MD at Freie Universitaet Berlin, Germany and an additional Medical Sciences MD from the University of Newcastle upon Tyne, United Kingdom. He completed residencies in General Surgery at Royal Berkshire Hospital and at Freeman Hospital in the UK and went on to complete a fellowship in Cardiothoracic Surgery and Cardiopulmonary Transplantation at the Cardiothoracic Centre in Newcastle upon Tyne, UK. He also completed a Cardiothoracic Surgery fellowship at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin, USA. Dr. Wigfield's clinical and research interests are in thoracic surgery, lung transplantation, robotic assisted surgery and minimally invasive thoracic surgery. He has a dedicated educational portfolio.
14673 Midway Rd., Suite 200
Addison, Texas, 75001
email@example.comBio coming soon...